Stop the Spread of Misinformation About Meds and Supplements for COVID-19

May 2020

Social media is aflutter with rumors about the impact of meds and supplements on COVID-19.

Blood pressure meds. Patients are hearing that ACE inhibitors (lisinopril, etc) and ARBs (losartan, etc) increase the risk of getting COVID-19 or having serious complications from it.

The thought is that the virus that causes COVID-19 gets into cells via "ACE2 receptors," and an ACE inhibitor or ARB might increase ACE2.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Practice Be Creative to Help Patients Get Their Meds
Infectious Diseases Stay Alert for Hydroxychloroquine Rxs to Prevent or Treat COVID-19
Shortages Minimize the Impact of Drug Shortages
Practice Enhance Patient Care During COVID-19 and Beyond
Infectious Diseases Stop the Spread of Misinformation About Meds and Supplements for COVID-19
Mental Health Watch for Signs of Distress in Patients or Colleagues
Insomnia Prevent Common Mix-Ups With Sleep Meds
Gastroenterology Avoid Errors With Talicia, a New Treatment for H. pylori
Generics Keep Nuances in Mind When Substituting With Generics

Stop the Spread of Misinformation About Meds and Supplements for COVID-19

Practical advice for a better career, with unlimited access to CE

Table of Contents